A Randomized Non-comparative Open-label Phase 1b/2 Study of Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer. "TRIFOUR Study"
NCT05181462 · ACTIVE NOT RECRUITING · Phase 2
We track 1 ClinicalTrials.gov studies led by Cantargia Ab. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Cantargia Ab.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Cantargia Ab currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Cantargia Ab conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.